Cargando…
Development of Site-Specific PEGylated Granulocyte Colony Stimulating Factor With Prolonged Biological Activity
Currently, amino-terminal PEGylated human granulocyte colony stimulating factor (huG-CSF) is used to prevent and treat neutropenia. Although huG-CSF has been used as a drug for more than 20 years, it has three significant drawbacks: (i) it relies on PEG aldehyde for PEGylation of the alpha-amino gro...
Autores principales: | Kumari, Monika, Sahni, Girish, Datta, Sonal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710547/ https://www.ncbi.nlm.nih.gov/pubmed/33330413 http://dx.doi.org/10.3389/fbioe.2020.572077 |
Ejemplares similares
-
Optimizing Granulocyte Colony-Stimulating Factor Transcript for Enhanced Expression in Escherichia coli
por: Datta, Sonal
Publicado: (2021) -
Preparation and Characterization of Site-Specific Fatty Chain-Modified Recombinant Human Granulocyte Colony Stimulating Factor
por: Wang, Xu-Dong, et al.
Publicado: (2022) -
Immune evaluation of granulocyte-macrophage colony stimulating factor loaded hierarchically 3D nanofiber scaffolds in a humanized mice model
por: Chen, Rui, et al.
Publicado: (2023) -
Five Days Granulocyte Colony-Stimulating Factor Treatment Increases Bone Formation and Reduces Gap Size of a Rat Segmental Bone Defect: A Pilot Study
por: Herrmann, Marietta, et al.
Publicado: (2018) -
Enhanced antifouling properties of marine antimicrobial peptides by PEGylation
por: Lou, Tong, et al.
Publicado: (2023)